Variation in the PTH Gene, hip fracture, and femoral neck geometry in elderly women

Calcified Tissue International

Volumn 86, Issue 5, 2010, Pages 359-366

  Tenne, M ^a   McGuigan, F E ^a   Ahlborg, H ^a   Gerdhem, P ^b,c   Akesson K ^a  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone architecture structure; Bone density technology; Fracture; Osteoporosis; PTH; PTHrP; Ultrasound

Indexed keywords

PARATHYROID HORMONE;

AGED; ARTICLE; BONE DENSITY; BONE STRUCTURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOTE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MORPHOMETRICS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ABSORPTIOMETRY, PHOTON; AGED; BONE DENSITY; CALCANEUS; DNA MUTATIONAL ANALYSIS; FEMALE; FEMUR NECK; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HIP; HIP FRACTURES; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77953363476     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-010-9351-6     Document Type: Article

References (47)

1. Melton LJ 3rd (1993) Hip fractures: a worldwide problem today and tomorrow. Bone 14(Suppl 1):S1-S8
2. Cooper C, Campion G, Melton LJ 3rd (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285-289
3. Arden NK et al (1996) The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins. J Bone Miner Res 11:530-534
4. Koller DL et al (2001) Genome screen for quantitative trait loci underlying normal variation in femoral structure. J Bone Miner Res 16:985-991
5. Flicker L et al (1996) Determinants of hip axis length in women aged 10-89 years: a twin study. Bone 18:41-45
6. Slemenda CW et al (1996) The genetics of proximal femur geometry, distribution of bone mass and bone mineral density. Osteoporos Int 6:178-182
7. Deng FY, Zhao LJ, Pei YF et al (2010) Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in Caucasians. Osteoporos Int 21:579-587
8. Howard GM et al (1998) Genetic and environmental contributions to the association between quantitative ultrasound and bone mineral density measurements: a twin study. J Bone Miner Res 13:1318-1327
9. Beamer WG et al (1996) Genetic variability in adult bone density among inbred strains of mice. Bone 18:397-403
10. Nordstrom A et al (2004) Interleukin-6 promoter polymorphism is associated with bone quality assessed by calcaneus ultrasound and previous fractures in a cohort of 75-year-old women. Osteoporos Int 15:820-826
11. Langdahl BL et al (2003) Polymorphisms in the transforming growth factor beta 1 gene and osteoporosis. Bone 32:297-310
12. Brommage R et al (1999) Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys. J Clin Endocrinol Metab 84:3757-3763
13. Neer M et al (1993) Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol. Osteoporos Int 3(Suppl 1):204-205
14. Hodsman AB et al (2003) Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosis. J Clin Endocrinol Metab 88:5212-5220
15. Chen P et al (2007) Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis. J Bone Miner Res 22:1173-1180
16. Recker RR et al (2009) Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84. Bone 44:113-119
17. Body JJ et al (2002) A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 87:4528-4535
18. Stroup JS et al (2007) Two-year changes in bone mineral density and T scores in patients treated at a pharmacist-run teriparatide clinic. Pharmacotherapy 27:779-788
19. Kronenberg HM (2003) Developmental regulation of the growth plate. Nature 423:332-336
20. Stewart AF et al (1980) Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N Engl J Med 303:1377-1383
21. Tenne M et al (2008) Genetic variation in the PTH pathway and bone phenotypes in elderly women: evaluation of PTH, PTHLH, PTHR1 and PTHR2 genes. Bone 42:719-727
22. Gerdhem P et al (2004) Association of the collagen type 1 (COL1A 1) Sp1 binding site polymorphism to femoral neck bone mineral density and wrist fracture in 1044 elderly Swedish women. Calcif Tissue Int 74:264-269
23. Gerdhem P et al (2005) Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporos Int 16:1425-1431
24. Gerdhem P, Akesson K (2007) Rates of fracture in participants and non-participants in the Osteoporosis Prospective Risk Assessment study. J Bone Joint Surg Br 89:1627-1631
25. Gerdhem P et al (2007) Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women. J Bone Miner Res 22:127-134
26. Yoshikawa T et al (1994) Geometric structure of the femoral neck measured using dual-energy X-ray absorptiometry. J Bone Miner Res 9:1053-1064
27. Karlsson MK et al (1998) Bone mineral density assessed by quantitative ultrasound and dual energy X-ray absorptiometry. Normative data in Malmo, Sweden. Acta Orthop Scand 69:189-193
28. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989
29. Dong SS et al (2009) Association analyses of RANKL/RANK/ OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians. Calcif Tissue Int 85:104-112
30. Cho K et al (2008) Polymorphisms in the endothelial nitric oxide synthase gene and bone density/ultrasound and geometry in humans. Bone 42:53-60
31. Rivadeneira F et al (2006) Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women. J Bone Miner Res 21:1443-1456
32. Moffett SP et al (2005) Tumor necrosis factor-alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women. J Clin Endocrinol Metab 90:3491-3497
33. Yerges LM et al (2009) Functional characterization of genetic variation in the Frizzled 1 (FZD1) promoter and association with bone phenotypes: more to the LRP5 story? J Bone Miner Res 24:87-96
34. Zmuda JM et al (2009) Association analysis of WNT10B with bone mass and structure among individuals of African ancestry. J Bone Miner Res 24:437-447
35. Rivadeneira F et al (2004) The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: the Rotterdam Study. J Bone Miner Res 19:1280-1290
36. Gong G et al (1999) Association of bone dimensions with a parathyroid hormone gene polymorphism in women. Osteoporos Int 9:307-311
37. Ahlborg HG et al (2005) Contribution of hip strength indices to hip fracture risk in elderly men and women. J Bone Miner Res 20:1820-1827
38. Faulkner KG et al (2006) Femur strength index predicts hip fracture independent of bone density and hip axis length. Osteoporos Int 17:593-599
39. Beck TJ (2007) Extending DXA beyond bone mineral density: understanding hip structure analysis. Curr Osteoporos Rep 5:49-55
40. Gregory JS, Aspden RM (2008) Femoral geometry as a risk factor for osteoporotic hip fracture in men and women. Med Eng Phys 30:1275-1286
41. Gluer CC et al (1994) Prediction of hip fractures from pelvic radiographs: the study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 9:671-677
42. Duan Y et al (2003) Structural and biomechanical basis of sexual dimorphism in femoral neck fragility has its origins in growth and aging. J Bone Miner Res 18:1766-1774
43. Lei SF et al (2005) The VDR, COL1A1, PTH, and PTHR1 gene polymorphisms are not associated with bone size and height in Chinese nuclear families. J Bone Miner Metab 23:501-505
44. Uusi-Rasi K et al (2005) Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women. Bone 36:948-958
45. Parkinson DB, Thakker RV (1992) A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism. Nat Genet 1:149-152
46. Kilav R, Silver J, Naveh-Many T (2001) A conserved cis-acting element in the parathyroid hormone 3'-untranslated region is sufficient for regulation of RNA stability by calcium and phosphate. J Biol Chem 276:8727-8733
47. Kaptoge S et al (2008) Prediction of incident hip fracture risk by femur geometry variables measured by hip structural analysis in the study of osteoporotic fractures. J Bone Miner Res 23:1892-1904 366